Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 38.88% is in line with its 5-year average of 39.31%, around the middle of its 5-year range (34.47%–42.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.45% below its 12-month average of 39.06%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 38.88%.
DEBT TO ASSETS RATIO
38.88%
DEBT TO ASSETS RATIO AVG TTM
39.06%
DEBT TO ASSETS RATIO AVG 3Y
38.65%
DEBT TO ASSETS RATIO AVG 5Y
39.31%
DEBT TO ASSETS RATIO AVG 10Y
40.75%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.45%
CURRENT VS 3Y AVG
+0.60%
CURRENT VS 5Y AVG
-1.10%
CURRENT VS 10Y AVG
-4.59%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+13543.17%
vs the sector median at left
Viatris Inc.
Market Cap
$19.74B
Debt to Assets Ratio
38.88%
TTM Avg
39.06%
3Y Avg
38.65%
5Y Avg
39.31%
Market Cap
$21.00B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.45B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.09B
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.38B
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $19.74B | 38.88% | 39.06% | 38.65% | 39.31% |
| STERIS plc (STE)vs › | $19.98B | 0.19% | N/A | N/A | N/A |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | 0.00% | N/A | N/A | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.45B | 0.33% | N/A | N/A | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $17.09B | 0.06% | N/A | N/A | N/A |
| Revvity, Inc. (RVTY)vs › | $16.00B | 0.28% | N/A | N/A | N/A |
| Solventum Corporation (SOLV)vs › | $15.38B | 0.37% | N/A | N/A | N/A |
| BioNTech SE (BNTX)vs › | $24.13B | 0.02% | N/A | N/A | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.67B | 0.07% | N/A | N/A | N/A |
| Incyte Corporation (INCY)vs › | $25.40B | 0.00% | N/A | N/A | N/A |
Debt/Assets
38.9%
Debt/Equity
0.96
Current Ratio
1.58
Interest Coverage
-5.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 38.88% |
| 2026-03-31 | 39.66% |
| 2025-12-31 | 39.53% |
| 2025-09-30 | 38.81% |
| 2025-06-30 | 38.42% |
| 2025-03-31 | 37.58% |
| 2024-12-31 | 34.47% |
| 2024-09-30 | 35.80% |
| 2024-06-30 | 38.34% |
| 2024-03-31 | 38.46% |
| 2023-12-31 | 38.53% |
| 2023-09-30 | 38.21% |
| 2023-06-30 | 38.72% |
| 2023-03-31 | 38.61% |
| 2022-12-31 | 39.04% |
| 2022-09-30 | 41.62% |
| 2022-06-30 | 41.60% |
| 2022-03-31 | 41.72% |
| 2021-12-31 | 42.59% |
| 2021-09-30 | 42.40% |
| 2021-06-30 | 42.60% |
| 2021-03-31 | 41.96% |
| 2020-12-31 | 42.50% |
| 2020-09-27 | 40.22% |
| 2020-06-28 | 41.19% |
| 2020-03-29 | 42.86% |
| 2019-12-31 | 41.35% |
| 2019-09-29 | 41.91% |
| 2019-06-29 | 41.77% |
| 2019-03-30 | 43.07% |
| 2018-12-30 | 42.21% |
| 2018-09-29 | 43.16% |
| 2018-06-29 | 44.14% |
| 2018-03-30 | 42.84% |
| 2017-12-30 | 40.95% |
| 2017-09-29 | 41.08% |
| 2017-06-29 | 42.22% |
| 2017-03-30 | 43.65% |
| 2016-12-30 | 44.56% |
| 2016-09-29 | 42.87% |
| 2016-06-29 | 46.23% |
| 2016-03-30 | 32.95% |
| 2015-12-30 | 32.81% |
| 2015-09-29 | 30.18% |
| 2015-06-29 | 37.44% |
| 2015-03-30 | 39.02% |
| 2014-12-30 | 53.63% |
| 2014-09-29 | 52.87% |
| 2014-06-29 | 52.71% |
| 2014-03-30 | 53.09% |
| 2013-12-30 | 52.58% |
| 2013-09-29 | 48.96% |
